Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at or call 800-767-3771 ext.  9339.

Recently Altera Corporation (ALTR - Analyst Report) declared that its clients can now access its latest Cyclone V GX FPGA development kit. The kit, which is considered as the first 28 nanometer(nm) development kit in the market, is especially designed for high-volume applications, such as industrial networking, surveillance cameras and automotive infotainment systems.

The new product has various features including FPGA boards, development software, reference designs and documentation. Management averred that, with the help of this new platform, clients will be able to easily increase the efficacy of their products with less time spent on designing. In addition, the latest kit would heighten the integration process of programmable logic devices (PLDs) and ASIC facilities and will also offer a unique low-power and minimized cost solution to customers.

Altera manufactures a wide array of products such as programmable logic devices (PLDs), which consist of field-programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs). These are standard semiconductor integrated circuits or chips, which customers program to execute required logic functions in their electronic systems.

Altera has a pipeline of 28 nanometer products, which it believes will maintain growth momentum in future. In the second quarter of 2012, Altera registered growth in the 28nm products. 28nm products grew 166% sequentially. Altera expects revenue from this node to exceed $20 million in the third quarter of 2012.

Altera’s main rival is Xilinx Inc. (XLNX - Analyst Report). Together, they hold nearly 87% of the PLD market. However, the company has a strategic advantage over Xilinx regarding its HardCopy offering (a new type of high performance application-specific integrated circuit for which Xilinx does not really have a competing product).

The current Zacks Consensus Estimates for the third quarter of 2012 and for 2012 are 46 cents and $1.79 per share, representing year-over-year growth of (19.78%) and (23.87%), respectively.

We currently maintain a ‘Neutral’ recommendation on Altera. The stock carries a Zacks #4 Rank, translating into a short-term (1-3 months) ‘Sell’ rating.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E HOUSECHINA EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%